Atea Pharmaceuticals Inc’s recently made public that its Director BERGER FRANKLIN M unloaded Company’s shares for reported $1.02 million on Dec 10 ’24. In the deal valued at $2.85 per share,359,606 shares were sold. As a result of this transaction, BERGER FRANKLIN M now holds 451,897 shares worth roughly $1.48 million.
Then, Franklin Berger bought 359,606 shares, generating $1,023,475 in total proceeds.
Before that, Sommadossi Jean-Pierre sold 33,941 shares. Atea Pharmaceuticals Inc shares valued at $137,318 were divested by the President, CEO, and Chairman at a price of $4.05 per share. As a result of the transaction, Sommadossi Jean-Pierre now holds 5,890,053 shares, worth roughly $19.26 million.
Morgan Stanley upgraded its Atea Pharmaceuticals Inc [AVIR] rating to an Equal-weight from a an Underweight in a research note published on August 13, 2024; the price target was increased to $6.88 from $2. A number of analysts have revised their coverage, including JP Morgan’s analysts, who decreased its forecast for the stock in early August from “a Neutral” to “an Underweight”. Morgan Stanley also remained covering AVIR and has decreased its forecast on January 06, 2022 with a “an Underweight” recommendation from previously “an Equal-weight” rating. SVB Leerink revised its rating on November 18, 2021. It rated AVIR as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of AVIR
On Friday, Atea Pharmaceuticals Inc [NASDAQ:AVIR] saw its stock fall -2.10% to $3.27. Over the last five days, the stock has lost -4.39%. Atea Pharmaceuticals Inc shares have fallen nearly -2.39% since the year began. Nevertheless, the stocks have fallen -5.22% over the past one year. While a 52-week high of $4.60 was reached on 01/03/25, a 52-week low of $2.75 was recorded on 01/10/25. SMA at 50 days reached $3.27, while 200 days put it at $3.56.
Levels Of Support And Resistance For AVIR Stock
The 24-hour chart illustrates a support level at 3.21, which if violated will result in even more drops to 3.15. On the upside, there is a resistance level at 3.35. A further resistance level may holdings at 3.43. The Relative Strength Index (RSI) on the 14-day chart is 49.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.01, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.93%. Stochastics %K at 43.42% indicates the stock is a holding.
How much short interest is there in Atea Pharmaceuticals Inc?
A steep rise in short interest was recorded in Atea Pharmaceuticals Inc stocks on 2024-12-13, growing by 0.54 million shares to a total of 3.18 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 2.64 million shares. There was a rise of 17.1%, which implies that there is a positive sentiment for the stock.
